基本信息
浏览量:0
职业迁徙
个人简介
Dr. Li started his academic career in cancer research in 1990s. His research findings have been accepted in several prestigious journals such as Science, Cancer Cell, Proc Natl Acad Sci U S A, Mol Cell Biol, Blood, Oncogene, J Biol Chem, etc., and are widely cited by research scientists. Knowing how to kill cancer cells has helped him to protect normal cells from injury-induced cell death in his present research of sepsis and trauma. Since 2005, Dr. Li has focused his study on pharmacological treatment of sepsis, traumatic hemorrhagic shock, traumatic brain injury (TBI), with emphasis on histone modifying enzymes, including histone deacetylase (HDAC) and peptidyl-arginine deiminase (PAD). His team developed a novel antibody against citrullinated histone H3 (CitH3), which is significantly different from commercially available one. Targeting CitH3 for early diagnosis/prognosis and treatment of sepsis has captured researchers’ attention in both academia and industry. These findings are being translated into the clinic now.
研究兴趣
论文共 149 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Tao Dong,Leonard Barasa, Xin Yu,Wenlu Ouyang, Liujiazi Shao, Chao Quan,Su He Wang, Jifeng Zhang, Morgan Salmon,Allan Tsung,Hasan B. Alam, Jianjie Ma,Paul R. Thompson,Yongqing Li
International Journal of Biological Sciencesno. 13 (2024): 5043-5055
Cell Reportsno. 3 (2024): 113942-113942
JCI INSIGHTno. 16 (2024)
Yujing Song,Erin Sandford,Yuzi Tian,Qingtian Yin, Andrew G. Kozminski,Shiuan-Haur Su,Tao Cai,Yuxuan Ye,Meng Ting Chung,Ryan Lindstrom,Annika Goicochea,Jenny Barabas,Mary Olesnavich,Michelle Rozwadowski,Yongqing Li,Hasan B. Alam,Benjamin H. Singer,Monalisa Ghosh,Sung Won Choi,Muneesh Tewari,Katsuo Kurabayashi
加载更多
作者统计
#Papers: 149
#Citation: 5151
H-Index: 38
G-Index: 67
Sociability: 6
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn